Two Simple Ways To Earn 24% a Year

For the past two weeks, I’ve been explaining to you why buying stocks of takeover targets can be so profitable. The thing is, this strategy isn’t for everyone. After all, it’s riskier than buying blue-chip stocks or diversified mutual funds. But as I’m about to share with you, there’s also… read more »

Tuesday, January 21, 2020

My 3-Step Process for Profiting from the M&A Boom

In my article last week, I predicted that private equity funds would be big buyers of companies in 2020. The next day, I saw this news headline: “Private equity group hunts $1 billion biotech buyout.” Such funds have $1.5 trillion they need to spend — so get ready for hundreds of… read more »

Tuesday, January 14, 2020

My #1 Strategy to Profit from 2020's Takeover Boom

There’s one key player behind any serious boom in M&A: private equity funds. You see, such firms have just one way to use their pile of money: on acquisitions! So when they’re flush with cash, there’ll be a boom. It’s as simple as that. Well, as it turns out, private… read more »

Tuesday, January 7, 2020

Top-Two Biotech Trades That Could Deliver 114% Returns

Biotech is the hottest sector to invest in right now — and the stats prove it: From the number of deals, to the size of the deals, it’s shaping up to be a record-setting year. Even better, acquirers are paying an average premium of 114%. That means, if you scoop… read more »

Tuesday, December 17, 2019

The Surprising Sector for Overnight Gains of 172%

Whoever said getting rich overnight in the market is impossible doesn’t know about biotech stocks. Yesterday, for example, ArQule (ARQL) surged 104%, and Synthorx (THOR) rallied 172%. This isn’t an anomaly, and it’s not too late to earn similar profits. Hands down, biotech is the hottest sector to invest in… read more »

Tuesday, December 10, 2019

A Potential "10-Bagger" in Biotech

One of the hottest fields in biotech right now is drug development for NASH. NASH is a type of liver disease which impacts an estimated 60 million people. Currently, no approved drug exists to treat it. This is creating a big opportunity for pharma companies. How big? Estimates range from… read more »

Tuesday, December 3, 2019

Instead of a 41% Loss, Earn a Profit of 881%

"We wanted flying cars and settled for 140 characters," declared PayPal founder Peter Thiel in a recent speech at the Manhattan Institute. His point? Innovation is Silicon Valley is sorely lacking right now: Instead of creating flying cars, our smartest entrepreneurs and engineers built Twitter. And instead of aiming to… read more »

Tuesday, November 26, 2019

The Surprising Trick to Supercharge Pot Profits

For a few weeks now, we’ve been telling you about the explosive legal cannabis market. And we’ve ushered in stats from dozens of sources to confirm the authenticity of this multi-billion-dollar opportunity. But today, I want you to throw out every one of the forecasts we’ve shown you. Why? Because… read more »

Tuesday, November 19, 2019

The Secret To Becoming a "Marijuana Millionaire"

For the past two weeks, we’ve been preparing you for an historic profit opportunity: The opportunity to invest in the booming marijuana market. So far, we’ve shown you the marijuana investments you should avoid… But today is different — today, we’ll finally reveal the investment you should dive into. This… read more »

Tuesday, November 12, 2019

How To Profit from Pot Stock "Pure-Plays"

Last week, I reminded you about a reliable way to spot winning investments: Patent filings. Patents are a surefire indicator that a company is on the cusp of innovation. And in many cases, such innovation can lead to a sharp increase in a company’s sales, profits, and share price. So… read more »

Tuesday, November 5, 2019